Product Images Bydureon Bcise
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 21 images provide visual information about the product associated with Bydureon Bcise NDC 0310-6540 by Astrazeneca Pharmaceuticals Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
figure 1 - bydureon 01
autoinjector pen - bydureon 45
P:\01_SPL\02_SPL_PREVIEW_SUBMISSION_FOR_PROOFING-TEMPORARY_HOLDING\BYDUREON BCISE\Harmonisation for Proofing\Figure 2.JPG - image 01
This is a table showing the results of a study comparing Exenatide to placebo for patients with an event over time. The table displays the HR (95% CI) at each timepoint up to 48 months from randomization, as well as the number of patients at risk for each treatment group.*
BYDUREON BCise 2 mg pen label - image 02
BYDUREON BCise is an extended-release injectable suspension medication that should be stored flat in a refrigerator at 36-46°F (2-8°C) and requires mixing before use. This medicine is for subcutaneous use only and is available by prescription only from AstraZeneca.*
BYDUREON BCise 2 mg carton - containing 4 single dose pens - image 03
BYDUREON BCise is an injectable suspension of exenatide extended-release that is used for subcutaneous use only. This medication is dispensed with an enclosed Medication Guide and must be stored flat in a refrigerator between 36-46°F. It comes in a pack of 4 single-dose autoinjectors, with each autoinjector delivering a 2 mg dose. It is prescribed by a medical practitioner, and the patient should use one autoinjector every week. This medication is produced by AstraZeneca.*
stop - image 10
lock - image 11
unlock - image 12
Figure K and L - image 13
remove cap - image 14
The text is describing a process or procedure with visual aids like Figure M and Figure N. However, it is difficult to understand the context only with this partial and fragmented information obtained through . Therefore, the description cannot be provided.*
push and hold - image 15
orange rod - image 16
disposal - image 17
autoinjector - image 2
The image shows a figure A with an orange cap, a window, and a locked position. The text mentions BYDUREON BCise medicine.*
wait 15 minutes - image 3
exp date - image 4
injection site - image 5
medicine cloudy - image 6
shake hard - image 7
not mixed - image 8
This text appears to be a label or an instruction related to a medicine or chemical product. It suggests that the product has not been mixed well and may have an uneven distribution of the active ingredient or other substances. The label also notes that the medicine may have settled on the bottom, top or sides of the container. Without further information or context, it is difficult to provide more specific details.*
mixed well - image 9
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.